Free Trial
NASDAQ:EXOZ

Exozymes (EXOZ) Stock Price, News & Analysis

$12.05 -1.48 (-10.94%)
As of 04:00 PM Eastern

About Exozymes Stock (NASDAQ:EXOZ)

Key Stats

Today's Range
$11.56
$14.31
50-Day Range
$9.95
$18.20
52-Week Range
$8.50
$23.99
Volume
29,112 shs
Average Volume
19,784 shs
Market Capitalization
$100.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

eXoZymes, Inc. is a development stage synthetic biochemical company. Its synthetic biology platform would enable the scalable exploration of many molecules and properties found in nature. The company was founded by Tyler Korman and Paul Opgenorth in April 2019 and is headquartered in Monrovia, NV.

Receive EXOZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Exozymes and its competitors with MarketBeat's FREE daily newsletter.

EXOZ Stock News Headlines

Top Picks for Trump’s Pro-Crypto America
Just Announced: What Trump’s Move Means for Crypto—Join Now 27 top names reveal urgent insights as Bitcoin rebounds
See More Headlines

EXOZ Stock Analysis - Frequently Asked Questions

Exozymes' stock was trading at $17.39 at the start of the year. Since then, EXOZ stock has decreased by 30.7% and is now trading at $12.05.
View the best growth stocks for 2025 here
.

Shares of EXOZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
4/24/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:EXOZ
Web
N/A
Fax
N/A
Employees
29
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$100.42 million
Optionable
N/A
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (NASDAQ:EXOZ) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners